DEANA JAMES: Open Payments
NPI 1487343810 · HANNIBAL, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,612 in 57 payments from 15 companies in 2025. Trend: 2023 $458 · 2024 $1,538 · 2025 $1,612
Food & beverage: $1,379Education: $233
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $373 |
| ABBVIE INC. | 7 | $195 |
| Galderma Laboratories, L.P. | 6 | $193 |
| Lilly USA, LLC | 6 | $185 |
| Regeneron Healthcare Solutions, Inc. | 5 | $153 |
| Novartis Pharmaceuticals Corporation | 5 | $119 |
| Incyte Corporation | 5 | $111 |
| E.R. Squibb & Sons, L.L.C. | 3 | $51 |
| Amgen Inc. | 2 | $48 |
| LEO Pharma Inc. | 2 | $48 |
Products named: TREMFYA, DUPIXENT, NEMLUVIO, OPZELURA, RINVOQ, TALTZ, EBGLYSS, SKYRIZI.
Industry payments across MO — which companies pay providers there.
